The genetic interface between gestational diabetes and type 2 diabetes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 1, 2012, Pages 36-40

  Konig, Manige ^a   Shuldiner, Alan R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

genome wide association study; Genomics; macrosomia; MODY; personalized medicine; SNPs

Indexed keywords

GLUCOKINASE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

BIRTH WEIGHT; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOKINASE GENE; HAPLOINSUFFICIENCY; HNF4A GENE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; KNCQ1 GENE; MACROSOMIA; MATURITY ONSET DIABETES MELLITUS; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PPARG GENE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TCF1 GENE; TCF2 GENE; TRANSCRIPTION FACTOR 7 LIKE 2 GENE;

ALLELES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOKINASE; HUMANS; INSULIN RESISTANCE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; TRANSCRIPTION FACTORS;

EID: 84055191054     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.626926     Document Type: Conference Paper

References (37)

1. National Institute of Diabetes and Digestive and Kidney Disease- National Diabetes Statistic 2011. Available at: http://diabetes.niddk.nih. gov/DM/PUBS/statistics. Accessed 9 september 2011.
2. McCarthy MI, Hattersley AT. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev Mol Diagn 2001;1:403-412. (Pubitemid 34654420)
3. Porter JR, Barrett TG. Monogenic syndromes of abnormal glucose homeostasis: Clinical review and relevance to the understanding of the pathology of insulin resistance and β cell failure. J Med Genet 2005;42:893-902. (Pubitemid 41811310)
4. Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974;43:339-357.
5. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-980.
6. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998;19:268-270. (Pubitemid 28309340)
7. Stoffel M, Bell KL, Blackburn CL, Powell KL, Seo TS, Takeda J, Vionnet N, et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 1993;42:937-940. (Pubitemid 23151590)
8. Zouali H, Vaxillaire M, Lesage S, Sun F, Velho G, Vionnet N, Chiu K, et al. Linkage analysis and molecular scanning of glucokinase gene in NIDDM families. Diabetes 1993;42:1238-1245. (Pubitemid 23259842)
9. Saker PJ, Hattersley AT, Barrow B, Hammersley MS, McLellan JA, Lo YM, Olds RJ, et al. High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia 1996;39:1325-1328. (Pubitemid 26356061)
10. Chiu KC, Go RC, Aoki M, Riggs AC, Tanizawa Y, Acton RT, Bell DS, et al. Glucokinase gene in gestational diabetes mellitus: Population association study and molecular scanning. Diabetologia 1994;37:104-110. (Pubitemid 24044715)
11. Allan CJ, Argyropoulos G, Bowker M, Zhu J, Lin PM, Stiver K, Golichowski A, Garvey WT. Gestational diabetes mellitus and gene mutations which affect insulin secretion. Diabetes Res Clin Pract 1997;36:135-141. (Pubitemid 27306816)
12. Ellard S, Beards F, Allen LI, Shepherd M, Ballantyne E, Harvey R, Hattersley AT. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 2000;43:250-253. (Pubitemid 30126833)
13. Kousta E, Ellard S, Allen LI, Saker PJ, Huxtable SJ, Hattersley AT, McCarthy MI. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med 2001;18:683-684. (Pubitemid 32823070)
14. Weng J, Ekelund M, Lehto M, Li H, Ekberg G, Frid A, Aberg A, et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes- associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 2002;25:68-71. (Pubitemid 41070785)
15. LukásováP, Vcelák J, VankováM, VejrazkováD, AndelováK, Bendlová B. Screening of mutations and polymorphisms in the glucokinase gene in Czech diabetic and healthy control populations. Physiol Res 2008;57 Suppl 1:S99-108.
16. de Las Heras J, Martínez R, Rica I, de Nanclares GP, Vela A, Castaño L; Spanish MODY group. Heterozygous glucokinase mutations and birth weight in Spanish children. Diabet Med 2010;27:608-610.
17. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339-2350.
18. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997;17:138-139.
19. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 1996;19:915-919. (Pubitemid 26301224)
20. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, et al. Molecular scanning of the human peroxisome proliferator activated receptor α (hPPAR α) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR α 2 missense mutation. Biochem Biophys Res Commun 1997;241:270-274. (Pubitemid 28020091)
21. Celi FS, Shuldiner AR. The role of peroxisome proliferator-activated receptor α in diabetes and obesity. Curr Diab Rep 2002;2:179-185.
22. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, et al. The common PPARα Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
23. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. The association between the peroxisome proliferator-activated receptor-α2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: A HuGE review and meta-analysis. Am J Epidemiol 2010;171:645-655.
24. Pappa KI, Gazouli M, Economou K, Daskalakis G, Anastasiou E, Anagnou NP, Antsaklis A. Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 2011;27:267-272.
25. Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S. PPAR-α2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2006;129:25-30. (Pubitemid 44633493)
26. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ, Andres R, et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-α2 gene with obesity in two Caucasian populations. Diabetes 1998;47:1806-1808. (Pubitemid 28476259)
27. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-α2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001;50:2172-2176. (Pubitemid 33643689)
28. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323.
29. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, Shuldiner AR. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: Replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006;55:2654-2659. (Pubitemid 44871170)
30. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250. (Pubitemid 44079339)
31. Freathy RM, Hayes MG, Urbanek M, Lowe LP, Lee H, Ackerman C, Frayling TM, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: Common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups. Diabetes 2010;59:2682-2689.
32. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589.
33. Staiger H, Machicao F, Fritsche A, Häring HU. Pathomechanisms of type 2 diabetes genes. Endocr Rev 2009;30:557-585.
34. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092-1097.
35. Shin HD, Park BL, Shin HJ, Kim JY, Park S, Kim B, Kim SH. Association of KCNQ1 polymorphisms with the gestational diabetes mellitus in Korean women. J Clin Endocrinol Metab 2010;95:445-449.
36. Cho YM, Kim TH, Lim S, Choi SH, Shin HD, Lee HK, Park KS, Jang HC. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009;52:253-261.
37. Lauenborg J, Grarup N, Damm P, Borch-Johnsen K, Jørgensen T, Pedersen O, Hansen T. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 2009;94:145-150.